Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Total Debt / Capital

Rigel Pharmaceuticals Total Debt / Capital Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Total Debt / Capital from 2010 to 2020.
  • Rigel Pharmaceuticals Total Debt / Capital for the quarter ending September 09, 2020 was $45m a 9.76% increase of 4m year over year
  • Rigel Pharmaceuticals Total Debt / Capital for the last 12 months ending September 09, 2020 was $45m a 9.76% increase of 4m year over year
  • Rigel Pharmaceuticals Annual Total Debt / Capital for 2019 was $40m a 98.81% increase of 40m from 2018
  • Rigel Pharmaceuticals Annual Total Debt / Capital for 2010 was $0m
Other Ratios Metrics:
  • Rigel Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $1m a 91.46% increase of 1m year over year
  • Rigel Pharmaceuticals Total Debt / Equity for the quarter ending September 09, 2011 was $0m a -827.75% decrease of 0m year over year
View Chart On Koyfin

Quarterly RIGL Total Debt / Capital Data

09/2020$45m
06/2020$41m
03/2020$31m
12/2019$40m
09/2019$36m
06/2019$28m
03/2019$25m
09/2011$0m
06/2011$0m
03/2011$0m

Annual RIGL Total Debt / Capital Data

2019$40m
2010$0m